Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

A Structural Explanation of the Effects of Dissociated Glucocorticoids on Glucocorticoid Receptor Transactivation

Xavier Dezitter, Jérôme Fagart, Solenne Taront, Michel Fay, Bernadette Masselot, Dominique Hétuin, Pierre Formstecher, Marie-Edith Rafestin-Oblin and Thierry Idziorek
Molecular Pharmacology February 2014, 85 (2) 226-236; DOI: https://doi.org/10.1124/mol.113.085860
Xavier Dezitter
Institut National de la Santé et de la Recherche Médicale U837, Institut de Recherche pour le Cancer de Lille, Lille, France (X.D., S.T., B.M., D.H., P.F., T.I.); Institut National de la Santé et de la Recherche Médicale U773, Centre de Recherche Biomédicale Bichat-Beaujon, CRB3 (J.F., M.F., M.-E.R.-O.); and Université Paris 7- Denis Diderot, site Bichat, Paris, France (J.F., M.F., M.-E.R.-O.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jérôme Fagart
Institut National de la Santé et de la Recherche Médicale U837, Institut de Recherche pour le Cancer de Lille, Lille, France (X.D., S.T., B.M., D.H., P.F., T.I.); Institut National de la Santé et de la Recherche Médicale U773, Centre de Recherche Biomédicale Bichat-Beaujon, CRB3 (J.F., M.F., M.-E.R.-O.); and Université Paris 7- Denis Diderot, site Bichat, Paris, France (J.F., M.F., M.-E.R.-O.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Solenne Taront
Institut National de la Santé et de la Recherche Médicale U837, Institut de Recherche pour le Cancer de Lille, Lille, France (X.D., S.T., B.M., D.H., P.F., T.I.); Institut National de la Santé et de la Recherche Médicale U773, Centre de Recherche Biomédicale Bichat-Beaujon, CRB3 (J.F., M.F., M.-E.R.-O.); and Université Paris 7- Denis Diderot, site Bichat, Paris, France (J.F., M.F., M.-E.R.-O.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel Fay
Institut National de la Santé et de la Recherche Médicale U837, Institut de Recherche pour le Cancer de Lille, Lille, France (X.D., S.T., B.M., D.H., P.F., T.I.); Institut National de la Santé et de la Recherche Médicale U773, Centre de Recherche Biomédicale Bichat-Beaujon, CRB3 (J.F., M.F., M.-E.R.-O.); and Université Paris 7- Denis Diderot, site Bichat, Paris, France (J.F., M.F., M.-E.R.-O.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernadette Masselot
Institut National de la Santé et de la Recherche Médicale U837, Institut de Recherche pour le Cancer de Lille, Lille, France (X.D., S.T., B.M., D.H., P.F., T.I.); Institut National de la Santé et de la Recherche Médicale U773, Centre de Recherche Biomédicale Bichat-Beaujon, CRB3 (J.F., M.F., M.-E.R.-O.); and Université Paris 7- Denis Diderot, site Bichat, Paris, France (J.F., M.F., M.-E.R.-O.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominique Hétuin
Institut National de la Santé et de la Recherche Médicale U837, Institut de Recherche pour le Cancer de Lille, Lille, France (X.D., S.T., B.M., D.H., P.F., T.I.); Institut National de la Santé et de la Recherche Médicale U773, Centre de Recherche Biomédicale Bichat-Beaujon, CRB3 (J.F., M.F., M.-E.R.-O.); and Université Paris 7- Denis Diderot, site Bichat, Paris, France (J.F., M.F., M.-E.R.-O.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre Formstecher
Institut National de la Santé et de la Recherche Médicale U837, Institut de Recherche pour le Cancer de Lille, Lille, France (X.D., S.T., B.M., D.H., P.F., T.I.); Institut National de la Santé et de la Recherche Médicale U773, Centre de Recherche Biomédicale Bichat-Beaujon, CRB3 (J.F., M.F., M.-E.R.-O.); and Université Paris 7- Denis Diderot, site Bichat, Paris, France (J.F., M.F., M.-E.R.-O.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie-Edith Rafestin-Oblin
Institut National de la Santé et de la Recherche Médicale U837, Institut de Recherche pour le Cancer de Lille, Lille, France (X.D., S.T., B.M., D.H., P.F., T.I.); Institut National de la Santé et de la Recherche Médicale U773, Centre de Recherche Biomédicale Bichat-Beaujon, CRB3 (J.F., M.F., M.-E.R.-O.); and Université Paris 7- Denis Diderot, site Bichat, Paris, France (J.F., M.F., M.-E.R.-O.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thierry Idziorek
Institut National de la Santé et de la Recherche Médicale U837, Institut de Recherche pour le Cancer de Lille, Lille, France (X.D., S.T., B.M., D.H., P.F., T.I.); Institut National de la Santé et de la Recherche Médicale U773, Centre de Recherche Biomédicale Bichat-Beaujon, CRB3 (J.F., M.F., M.-E.R.-O.); and Université Paris 7- Denis Diderot, site Bichat, Paris, France (J.F., M.F., M.-E.R.-O.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

There is a therapeutic need for glucocorticoid receptor (GR) ligands that distinguish between the transrepression and transactivation activity of the GR, the later thought to be responsible for side effects. These ligands are known as “dissociated glucocorticoids” (dGCs). The first published dGCs, RU24782 (9α-fluoro-11β-hydroxy-16α-methylpregna-21-thiomethyl-1,4-diene-3,20-dione) and RU24858 (9α-fluoro-11β-hydroxy-16α-methylpregna-21-cyanide-1,4-diene-3,20-dione), do not have the 17α-hydroxyl group that characterizes dexamethasone (Dex; 9α-fluoro-11β,17α,21-trihydroxy-16α-methylpregna-1,4-diene-3,20-dione), and they differ from one another by having C21-thiomethyl and C21-cyanide moieties, respectively. Our aim was therefore to establish the structural basis of their activity. Both RU24782 and RU24858 induced a transactivation activity highly dependent on the GR expression level but always lower than dexamethasone. They also display less ability than dexamethasone to trigger steroid receptor coactivator 1 (SRC-1) recruitment and histone H3 acetylation. Docking studies, validated by mutagenesis experiments, revealed that dGCs are not anchored by Gln642, in contrast to Dex, which is hydrogen bonded to this residue via its 17α-hydroxyl group. This contact is essential for SRC-1 recruitment and subsequent dexamethasone-induced GR transactivation, but not transrepression. The ability of dGCs to make contacts with Ile747, for both RU24858 and RU24782 and with Asn564 for RU24858 are not strong enough to maintain GR in a conformation able to efficiently recruit SRC-1, unless SRC-1 is overexpressed. Overall, our findings provide some structural guidelines for the synthesis of potential new dissociated glucocorticoids with a better therapeutic ratio.

Footnotes

    • Received February 27, 2013.
    • Accepted November 12, 2013.
  • ↵1 Current affiliation: Institut de Chimie Pharmaceutique Albert Lespagnol, Lille, France.

  • This work was supported by the Institut National de la Santé et de la Recherche Médicale and by the Institut pour la Recherche sur le Cancer de Lille (to X.D.).

  • dx.doi.org/10.1124/mol.113.085860.

  • Copyright © 2013 by The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 85 (2)
Molecular Pharmacology
Vol. 85, Issue 2
1 Feb 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A Structural Explanation of the Effects of Dissociated Glucocorticoids on Glucocorticoid Receptor Transactivation
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Molecular Determinants of dGC Effects

Xavier Dezitter, Jérôme Fagart, Solenne Taront, Michel Fay, Bernadette Masselot, Dominique Hétuin, Pierre Formstecher, Marie-Edith Rafestin-Oblin and Thierry Idziorek
Molecular Pharmacology February 1, 2014, 85 (2) 226-236; DOI: https://doi.org/10.1124/mol.113.085860

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Molecular Determinants of dGC Effects

Xavier Dezitter, Jérôme Fagart, Solenne Taront, Michel Fay, Bernadette Masselot, Dominique Hétuin, Pierre Formstecher, Marie-Edith Rafestin-Oblin and Thierry Idziorek
Molecular Pharmacology February 1, 2014, 85 (2) 226-236; DOI: https://doi.org/10.1124/mol.113.085860
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
  • Benzbromarone relaxes airway smooth muscle via BK activation
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics